The Valley Desk

ArticlePediatric blood & cancerPublished

Efficacy and Tolerability of Topotecan/Cyclophosphamide/Dinutuximab in Relapsed and Refractory High-Risk Neuroblastoma: A Multi-Institutional Retrospective Study

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Children’s Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania. Affiliation source

Publication record

Type
Article
Venue
Pediatric blood & cancer
Published
Subject terms
Humans; Neuroblastoma; Neoplasm Recurrence, Local; Cyclophosphamide; Topotecan; Antineoplastic Combined Chemotherapy Protocols; Antibodies, Monoclonal; Prognosis; Survival Rate; Retrospective Studies; Follow-Up Studies; Drug Resistance, Neoplasm
PubMed ID
41823156
PubMed Central ID
PMC13271835
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal